The Great Cholesterol Scam and the Dangers of Statins

This piece argues that cholesterol is not the root cause of cardiovascular disease and that the dominant cholesterol-centric model and widespread statin use were produced and perpetuated by vested interests. It revisits the Ancel Keys versus John Yudkin debate, claiming Keys cherry-picked countries to link saturated fat and cholesterol to heart disease while unpublished trials allegedly showed that lowering cholesterol with vegetable oils increased mortality. It presents an alternate model in which atherosclerotic lesions result from the body’s clotting and healing processes, not cholesterol accumulation, and asserts that multiple studies and reviews fail to show a benefit from lowering cholesterol in reducing heart disease or overall mortality.

The critique extends to statin therapy and the institutions promoting it: statin prescriptions have surged, guidelines shifted to treat a numeric target, and trial data are portrayed as opaque and industry-influenced. Independent reanalyses are cited that claim taking a statin for five years extends life by only a few days on average, with most benefit in men, while harms and serious adverse effects are characterized as widespread. Conflicts of interest among guideline panelists and selective reporting by pharmaceutical-funded collaborations are emphasized, and the author calls for focusing on overlooked causes and alternative treatments for heart and vascular disease.